mardi 7 mars 2017

Onco Actu du 7 mars 2017

3.1.1 Tabac - e-cigs

Global E-Cigarette Market Size, Share, Development, Growth and Demand Forecast to 2022 [ResearchAndMarkets]

3.2 Prévention - Obésité

The Microbiome and Human Obesity: Wait a Minute [In the Pipeline]

4.12 Biopsies liquides

OncoCyte says study confirms accuracy of lung cancer blood test [Reuters]

5. Traitements

A new way to reset gene expression in cancer cells shows promise for leukemia treatment [The Rockefeller University]

5.12.5 Immunothérapies - Pharma

Advaxis gets green light for trial of Amgen-partnered neoantigen cancer vaccine [FierceBiotech]

Race Tightens for Next Wave of Cancer Drugs [Wall Street Journal]

5.2 Pharma

Exelixis' Cabozantinib Granted Orphan Drug Designation for the Treatment of Hepatocellular Carcinoma [Exelixis]

TG Therapeutics shares rocket up on successful PhIII leukemia study, teeing up a shot at accelerated FDA OK [EndPoints]

TG Therapeutics' leukemia drug clears hurdle in key study [Reuters]

5.3 Traitements - FDA, EMA, NICE...

FDA Lifts Clinical Hold on Seattle Genetics’ Phase 1 Trials of Vadastuximab Talirine [Seattle Genetics]

Seattle Genetics to Resume Leukemia Drug Trials After FDA Lifts Hold [Xconomy]

FDA lifts its hold on vadastuximab talirine after Seattle Genetics adds new safeguards [EndPoints]

FDA lifts hold on Seattle Genetics drug trials [Reuters]

5.6 ESMO

Targeted Anticancer Therapies (TAT) Congress Becomes an Annual ESMO Event [ESMO]

5.9 AACR

New AACR Social Media Policies for Scientific Meetings Strive for Balance [Cancer Research Catalyst]

6. Lutte contre les cancers

Measuring the quality of cancer care [Healthcare Economist]

Exercise better than drugs for cancer fatigue [Reuters]

6.1 Observation

Soy tied to longer life after breast cancer [Reuters]

6.10.1 Politiques (USA)

Federal right-to-try legislation undermines patient protection and drug testing [STAT]

6.5 Médecines alternatives

The Texas Medical Board lets Stanislaw Burzynski off lightly: A cautionary tale of the failure of regulating medicine [Science-Based Medicine]

6.7 DMP, Big Data & applis

Mark Cuban Asked And I Respond: Will This Company Transform The Economics and Results of Healthcare? [Dr. Len]

6.8 Communication

Null but not void: Why health journalists need to stop ignoring negative studies [HealthNewsReview]

6.9 Controverses

Soon-Shiong’s company stock falls 23 percent following STAT report [STAT]

How the world’s richest doctor gave away millions — then steered the cash back to his company [STAT]